205 related articles for article (PubMed ID: 24810788)
1. The diagnostic value of DNA methylation in leukemia: a systematic review and meta-analysis.
Jiang D; Hong Q; Shen Y; Xu Y; Zhu H; Li Y; Xu C; Ouyang G; Duan S
PLoS One; 2014; 9(5):e96822. PubMed ID: 24810788
[TBL] [Abstract][Full Text] [Related]
2. Meta-analyses of methylation markers for prostate cancer.
Jiang D; Shen Y; Dai D; Xu Y; Xu C; Zhu H; Huang T; Duan S
Tumour Biol; 2014 Oct; 35(10):10449-55. PubMed ID: 25053593
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation and leukemia susceptibility in China: Evidence from an updated meta-analysis.
Jiang D; Li Y; Hong Q; Shen Y; Xu C; Xu Y; Zhu H; Dai D; Ouyang G; Duan S
Mol Clin Oncol; 2016 Sep; 5(3):193-207. PubMed ID: 27588182
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis of DNA methylation biomarkers in hepatocellular carcinoma.
Zhang C; Li J; Huang T; Duan S; Dai D; Jiang D; Sui X; Li D; Chen Y; Ding F; Huang C; Chen G; Wang K
Oncotarget; 2016 Dec; 7(49):81255-81267. PubMed ID: 27835605
[TBL] [Abstract][Full Text] [Related]
5. Clinical potential of DNA methylation in gastric cancer: a meta-analysis.
Sapari NS; Loh M; Vaithilingam A; Soong R
PLoS One; 2012; 7(4):e36275. PubMed ID: 22558417
[TBL] [Abstract][Full Text] [Related]
6. [Id4 gene methylation for detection of minimal residual disease in acute leukemia].
Zhao Y; Yu L; Wang QS; Li HH; Bo J; Wang SH; Jin HJ; Lou FD
Zhonghua Xue Ye Xue Za Zhi; 2006 May; 27(5):298-301. PubMed ID: 16875575
[TBL] [Abstract][Full Text] [Related]
7. CDKN2A promoter methylation and hepatocellular carcinoma risk: A meta-analysis.
Zhou Y; Wang XB; Qiu XP; Shuai Zhang ; Wang C; Zheng F
Clin Res Hepatol Gastroenterol; 2018 Dec; 42(6):529-541. PubMed ID: 30143452
[TBL] [Abstract][Full Text] [Related]
8. Monitoring of methylation changes in 9p21 region in patients with myelodysplastic syndromes and acute myeloid leukemia.
Cechova H; Lassuthova P; Novakova L; Belickova M; Stemberkova R; Jencik J; Stankova M; Hrabakova P; Pegova K; Zizkova H; Cermak J
Neoplasma; 2012; 59(2):168-74. PubMed ID: 22248274
[TBL] [Abstract][Full Text] [Related]
9. [Methylation of Id4 gene promoter in acute leukemia].
Zhao Y; Wang QS; Dou LP; Bo J; Li HH; Jing Y; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Dec; 15(6):1156-60. PubMed ID: 18088456
[TBL] [Abstract][Full Text] [Related]
10. Prognostic role of microRNA-155 in patients with leukemia: A meta-analysis.
Zhang X; Wang Y; Guo Q; Diao Y; Liu H; Song G; Wang W; Zhang Z; Yin H; Li L
Clin Chim Acta; 2018 Aug; 483():6-13. PubMed ID: 29654787
[TBL] [Abstract][Full Text] [Related]
11. Gene promoter methylation and cancer: An umbrella review.
Bouras E; Karakioulaki M; Bougioukas KI; Aivaliotis M; Tzimagiorgis G; Chourdakis M
Gene; 2019 Aug; 710():333-340. PubMed ID: 31202904
[TBL] [Abstract][Full Text] [Related]
12. Clinical and prognostic effects of
Xia L; Zhang W; Gao L
Biomarkers; 2019 Nov; 24(7):700-711. PubMed ID: 31382782
[No Abstract] [Full Text] [Related]
13. Systematic review supports the role of DNA methylation in the pathophysiology of preeclampsia: a call for analytical and methodological standardization.
Cirkovic A; Garovic V; Milin Lazovic J; Milicevic O; Savic M; Rajovic N; Aleksic N; Weissgerber T; Stefanovic A; Stanisavljevic D; Milic N
Biol Sex Differ; 2020 Jul; 11(1):36. PubMed ID: 32631423
[TBL] [Abstract][Full Text] [Related]
14. Methionine synthase reductase A66G polymorphism and leukemia risk: evidence from published studies.
Fang DH; Ji Q; Fan CH; An Q; Li J
Leuk Lymphoma; 2014 Aug; 55(8):1910-4. PubMed ID: 24261678
[TBL] [Abstract][Full Text] [Related]
15. Meta-analysis of CDKN2A methylation to find its role in prostate cancer development and progression, and also to find the effect of CDKN2A expression on disease-free survival (PRISMA).
Cao Z; Wei L; Zhu W; Yao X
Medicine (Baltimore); 2018 Mar; 97(12):e0182. PubMed ID: 29561434
[TBL] [Abstract][Full Text] [Related]
16. Aberrant promoter methylation of the CHD1 gene may contribute to the pathogenesis of breast cancer: a meta-analysis.
Gu X; Xue JQ; Zhu X; Ye MS; Zhang WH
Tumour Biol; 2014 Sep; 35(9):9395-404. PubMed ID: 24952891
[TBL] [Abstract][Full Text] [Related]
17. Association of Interferon Gamma +874T/A Polymorphism and Leukemia Risk: A Meta-Analysis.
Wu Z; Sun Y; Zhu S; Tang S; Liu C; Qin W
Medicine (Baltimore); 2016 Mar; 95(12):e3129. PubMed ID: 27015189
[TBL] [Abstract][Full Text] [Related]
18. Early aberrant DNA methylation events in a mouse model of acute myeloid leukemia.
Sonnet M; Claus R; Becker N; Zucknick M; Petersen J; Lipka DB; Oakes CC; Andrulis M; Lier A; Milsom MD; Witte T; Gu L; Kim-Wanner SZ; Schirmacher P; Wulfert M; Gattermann N; Lübbert M; Rosenbauer F; Rehli M; Bullinger L; Weichenhan D; Plass C
Genome Med; 2014; 6(4):34. PubMed ID: 24944583
[TBL] [Abstract][Full Text] [Related]
19. Aberrant promoter methylation of the vimentin gene may contribute to colorectal carcinogenesis: a meta-analysis.
Li YW; Kong FM; Zhou JP; Dong M
Tumour Biol; 2014 Jul; 35(7):6783-90. PubMed ID: 24729088
[TBL] [Abstract][Full Text] [Related]
20. DNA methylation of tumor suppressor genes in clinical remission predicts the relapse risk in acute myeloid leukemia.
Agrawal S; Unterberg M; Koschmieder S; zur Stadt U; Brunnberg U; Verbeek W; Büchner T; Berdel WE; Serve H; Müller-Tidow C
Cancer Res; 2007 Feb; 67(3):1370-7. PubMed ID: 17283175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
